David Attenborough …99 in 2 days
David Attenborough …99 in 2 days
ACMG last week was a blast, long-read to increase diagnostic yield ✔️, methylation for simoustaneous functional insights ✔️ and Dr Wendy Chung presentation showing 24% increase diagnostic yield on rare disease samples from 350+ families with #nanopore sequencing @nanoporetech.com
We are hosting a Knowledge exchange on data analysis for rare diseases using EPI2ME and our data interpretation partners @geneyx.bsky.social and @fabricgenomics at the end of the month register: nanoporetech.com/about/events...
even in well-characterised genes, long-associated with a disease subtype there is value in digging further to discover new variants and their function #alzheimers www.nature.com/articles/s41...
24kb locus with segmental duplication resolved www.researchsquare.com/article/rs-5...
#nanopore sequencing to resolve different subtypes of PWS and AS jmg.bmj.com/content/earl...
Selected areas of Human rRNAs showing modification calls in IGV. Samples sequenced by ONT direct RNA sequencing with experimental Remora models calling m6A, m5C, PseudoU, and all 4 2'Ome modifications.
We have been busing working on models to detect all 2'Ome-RNA modified nucleotides on top of PseudoU, m6A, m5C and Inosine using @nanoporetech.com direct RNA sequencing.
This is still very preliminary but here are a few examples of what it looks like on Human #rRNA prepared with standard lib prep 🤩
We are proud to announce a collaboration with UK Biobank to create the world’s first large-scale #epigenetic dataset of 50k participants. The dataset will unlock crucial insights into how #epigenetics drives disease & the breakthroughs to treat them.
Read more: nanoporetech.com/news/oxford-...